We are a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer.
Boston Business Journal’s Best Places to Work, https://www.bizjournals.com/boston/news/2023/04/12/bbj-announces-2023-best-places-to-work-extra-large.html, 2023 TOP 100 Top-Innovator (Germany), https://www.top100.de/foundation-medicine-gmbh-2023/, 2023